Navigation Links
Good liquid, bad liquid
Date:2/5/2009

Immediately after the liquid explosive bomb plot was uncovered in London in August 2006, the Department of Homeland Security's Science & Technology Directorate (S&T) looked to to find ways to not only detect liquids in baggage and on passengers, but also to figure out what those liquids are. Now, S&T-sponsored scientists at Los Alamos National Laboratory have developed a possible solution. They have successfully tested a liquid explosive detection system that may eventually have many security applications around the country. Machines ready for an operational environment remains a few years away, but the technology is promising to quickly detect liquid explosives within a few years.

Stephen Surko is the Program Manager for the research at S&T. He says, "Los Alamos has done an outstanding job in a relatively short period of time."

When S&T last reported on this technology, it was still in the conceptual phase, and went by a different name (http://www.dhs.gov/xres/programs/gc_1220462488919.shtm). Now known as MagViz, the system adapts the magnetic resonance imaging (MRI) technology, typically used by doctors to scan brains, to screen for harmful liquids, gels, and lotions.

Similar in size and shape to an X-ray machine, a working MagViz prototype was on display at the Albuquerque International Sunport in December. The system is linked to an electronic database that currently contains chemical fingerprints for 50 liquids. As shown in the images here, if a threat liquid is identified, the machine marks the container on the display screen with a red dot. Harmless liquids like water or shampoo are marked with a green dot. If MagViz cannot identify a liquid it marks the container with a yellow dot, requiring further inspection. (See the Los Alamos video for more on the science behind MagViz.)

As development of the system continues, more liquids will be ad
'/>"/>

Contact: John Verrico
john.verrico@dhs.gov
202-527-3625
US Department of Homeland Security - Science and Technology
Source:Eurekalert  

Page: 1 2

Related biology news :

1. Research exposes the risk to infants from the chemicals used in liquid medicines
2. Videos extract mechanical properties of liquid-gel interfaces
3. Liquid crystal phases of tiny DNA molecules point up new scenario for first life on Earth
4. Researchers develop liquid crystal pharmaceuticals to fight cancer and other diseases
Post Your Comments:
*Name:
*Comment:
*Email:
Related Image:
Good liquid, bad liquid
(Date:7/8/2015)... NEW YORK , July 8, 2015 ... today announced BD & Guidepoint Mentor, ... free access to Guidepoint,s expert network services. ... developing cutting-edge technologies to improve healthcare delivery and outcomes ... manager, each start-up entrepreneur will be able to directly ...
(Date:7/8/2015)... -- The consumer products industry for innovative tech ... such as wearables, smart wallets & other smart technology are ... continues to rapidly grow.  Biometrics & Wearable Device Companies in ... Inc. (NASDAQ: GOOG ), Apple Inc. (NASDAQ: AAPL ... GPRO ) and Baidu Inc. (NASDAQ: BIDU ) ...
(Date:7/7/2015)... 2015  Based on its recent analysis of ... Credence ID, LLC with the 2015 Asia-Pacific ... Year Award. Credence ID has developed a low-cost, ... of offering enrollment and identification solutions to the ... was formed by experts from the mobile biometrics ...
Breaking Biology News(10 mins):BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 2BD and Guidepoint Team to Connect Healthcare Start-up Companies With Business and Scientific Experts 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 2Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 3Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 4Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 5Consumers Flock to This Summer's Must Have Tech Gadgets as Latest Digital Wallets, Smart Technology & Wearable Products Continue to Grow in Popularity & Functionality 6Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 2Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 3Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 4Frost & Sullivan Acknowledges the Distinctive Customer-focused Attributes of Credence ID's Mobile Biometric Product Suite 5
... Broadlawns Medical Center is reading palms in order to ... plan and commitment to be the Iowa leader in Electronic ... scanners to register and check-in patients. The new system, called ... Broadlawns Medical Center as part of a week-long launch.   ...
... children were born in public clinics in Denmark, projecting a net ... 50 years respectively. The authors of the study calculated that reductions ... to cost savings of 67 - 111 million for the Danish ... 50 years of age, the government would have lost 74 - ...
... Results from a study of over 50 000 pregnancies ... pregnancy was confirmed gave birth to babies with a ... never smoked, Professor Nick Macklon, from the Department of ... annual conference of the European Society of Human Reproduction ...
Cached Biology News:Broadlawns Installs First-in-Iowa Biometric Patient Identity Security System 2Broadlawns Installs First-in-Iowa Biometric Patient Identity Security System 3The long-term fiscal impact of funding cuts for IVF in Denmark 2Giving up smoking averts the adverse birth outcomes associated with tobacco 2
(Date:7/29/2015)... July 30, 2015 Sanofi, ... publie ses résultats pour le premier semestre 2015. ... les résultats. Visionner l,interview vidéo et ... Au sommaire de l,interview :  ... Moteurs de croissance - Diabète ...
(Date:7/29/2015)... , July 29, 2015 US-Australian drug discovery ... today confirmed it is committed to progressing its ground-breaking ... as practicable and to ensure the Company delivers the ... Officer, Iain Ross , said the Company currently ... lead pre-clinical programs, discovery programs and academic partnerships and ...
(Date:7/29/2015)... 29, 2015 /PRNewswire/ - BioAmber Inc. (NYSE: BIOA ) ... Chief Financial Officer has resigned.  The Company has hired ... who retired in December 2014, as full time interim ... successor.     Andy Ashworth began his ... a smooth transition.  Andy was the Company,s CFO from ...
(Date:7/29/2015)...  AsureQuality and Ubiquitome have agreed to collaborate ... food and primary production sectors. The collaboration will ... the Freedom4. AsureQuality provides quality assurance ... shelf for producers, processors and Competent Authorities around ... control and pest management and surveillance programmes. ...
Breaking Biology Technology:Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 2Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 3Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 4Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 5Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 6Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 7Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 8Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 9Newly Appointed Acting CEO Outlines Immediate Plans for Novogen 10BioAmber Announces Change in Chief Financial Officer 2BioAmber Announces Change in Chief Financial Officer 3AsureQuality and Ubiquitome Partner on Applications for Mobile Molecular Food Safety Testing 2
... Loestrin 24 Fe and Taclonex, ST. DAVID,S, Bermuda, ... today announced its results for the quarter and year,ended ... 31, 2007,totaled $227.7 million, an increase of 10.3%, over ... 31, 2007 totaled $899.6 million, an,increase of 19.2% over ...
... 29 Wyeth Pharmaceuticals,a division of Wyeth (NYSE: ... its,collaboration agreements with Solvay Pharmaceuticals for the development,and ... in earlier,stages of development for the potential treatment ... the collaboration with Solvay after assessing the,opportunity for ...
... SAN FRANCISCO, Calif., Feb. 28 ,Exelixis, Inc. (Nasdaq: ... director of investor relations, will present at the,Susquehanna SIGnificant ... a.m. PT on Tuesday, March 4, 2008., The ... the Event,Calendar page under Investors on the Exelixis website ...
Cached Biology Technology:Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 2Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 3Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 4Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 5Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 6Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 7Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 8Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 9Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 10Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 11Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 12Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 13Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 14Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 15Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 16Warner Chilcott Reports Operating Results for the Quarter and Year ended December 31, 2007 17Wyeth Pharmaceuticals Ends Collaboration Agreements with Solvay Pharmaceuticals for Bifeprunox and Other Compounds 2
Mouse monoclonal [Ley 37D/G6] to LKB1 ( Abpromise for all tested applications). entrezGeneID: 6794 SwissProtID: Q15831...
... phase reagent for Virus ... & unique water insoluble ... detergents and chaotropes; Engineered ... non-envelop viruses while preserving ...
Integrins Sampler Kit 10g each...
PKC Sampler Kit 10 mu g each...
Biology Products: